TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Postoperative analgesia quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time until the infant was ready for discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Flow-Mediated Dilation (% FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean pain severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved survival from septic shock
Endpoint domain: Mortality/survival
Primary endpoint: Decreased adjusted 90-day mortality
Endpoint domain: Mortality/survival
Primary endpoint: Faster resolution of shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual victimization
Endpoint domain: Mortality/survival
Primary endpoint: GAD65-induced IL-5 and IL-13 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FOXP3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Metronidazole plasma AUC((0‐ infinity ))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metronidazole C(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary excretion of unchanged metronidazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported mobility improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: plasma concentrations of rivastigmine or NAP226-90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distal displacement of maxillary molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: restriction of forward maxillary growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clockwise rotation of the maxilla
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: narcotic use reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQL improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Success rate of maintaining pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: Miscarriage rate
Endpoint domain: Mortality/survival
Primary endpoint: Repeat treatment rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with services
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: High-fat food consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Foot odor level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary TTCA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of using ventilator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of ventilator weaning within 3 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative attachment level (RAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to deliver psychosocial care
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction of LDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peak air flow readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of prematurity
Endpoint domain: Mortality/survival
Primary endpoint: recovery orientation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: internalized stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: drainage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seroma formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of seroma aspirations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCO area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCO severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of at least one postoperative complication
Endpoint domain: Adverse events/effects
Primary endpoint: Fewer days of quetiapine prescribed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Relative bioavailability of oral syrup compared to intramuscular administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic steady state concentrations for antipyresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laxative intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gross Motor Function Measure E score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life impact
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean endurance time at week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory capacity at isotime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breathing discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle between puborectal muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaper changing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean decayed, missing, and filled teeth (DMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoperation rates
Endpoint domain: Mortality/survival
Primary endpoint: Overall satisfaction rates
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total esophageal acid exposure times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of anterior knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma levels of IL2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma levels of CCL5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in anxiety response intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return-to-work rate 12 months after rehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Subjective working capacity fully re-established
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean reduction in pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: throwing velocity with the soccer ball
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in physical ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 30-day event rate for death or myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Analgesic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shock duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ventricular-arterial coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increased CSBM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Relief in the severity of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hamilton Rating Scale for Depression raw score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission (Hamilton Rating Scale for Depression <10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative cellular immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Post-exercise reduction in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: QTcF change from baseline (ΔQTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Procedural quality of PBLS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: progressive sperm motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative pulmonary complications (PPCs)
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of postoperative hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Use of gloves and gear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in total number of pesticides used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported dermal pesticide exposure
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in haematological and biochemical variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rates of healing of cavities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median reduction in SSF from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QOLIE‐31 scores increase from baseline
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MADRS scores decrease from baseline
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean difference of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: composite clinical endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality-adjusted life-year (QALY) gains
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: drop jump height increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with ACh-induced coronary spasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration from stage 2 breast development to menarche
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taller near-adult height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leaner body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arrhythmias within 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Urethral complications (UCF, stricture urethra, meatal stenosis)
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of eyelid cleaning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to overt or silent CAD
Endpoint domain: Mortality/survival
Primary endpoint: Ischemia or new scar findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average serum hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of patients reaching study termination
Endpoint domain: Mortality/survival
Primary endpoint: long-term retention of understanding
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean time to complete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cmax of ACT-541468
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-∞ of ACT-541468
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t½ of ACT-541468
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamstring muscle flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival (OS) at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free survival rate at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Oral self-care improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA expression of IL-12A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lesion depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with primary care visit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: latissimus dorsi flap twitching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain and tightness of the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symmetry and shape of the breasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early neonatal deaths
Endpoint domain: Mortality/survival
Primary endpoint: delays in receiving care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in grass-specific IgE antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proptosis measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosage of propofol required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global satisfaction among patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of cardiorespiratory events
Endpoint domain: Adverse events/effects
Primary endpoint: best-corrected low-contrast distance VA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: near phoria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intersystem reliability of S-POP classification system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first appearance of twitch depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to maximum twitch inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intubating conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Urinary protein values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Post-procedure perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enzymatic infarct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric mucosal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Liver iron concentration (LIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified Rankin score ≤1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: National Institutes of Health Stroke Scale ≤1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in cognitive test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of successful tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of patient motion measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability in fundamental frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms related to side effects of chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in positive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Macular Pigment Optical Density (MPOD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral Inhibition Strength (LIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: homeostasis model of assessment-insulin resistance (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement in pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Achieving adequate analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Repigmentation of at least 70% of the treated area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: in-hospital stroke rate
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life scores of cough questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: posttraumatic symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dystocia rate
Endpoint domain: Adverse events/effects
Primary endpoint: Cesarean delivery rate
Endpoint domain: Adverse events/effects
Primary endpoint: Thickness of hyperkeratotic skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin barrier function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean hospitalization time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Quality of physician-patient interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relative energy of low frequency band (LF) of systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: post-procedure nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: overall satisfaction with sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Combined endpoint of death or nonfatal myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Any adverse cardiac event
Endpoint domain: Adverse events/effects
Primary endpoint: Persistent or recurrent Canadian Cardiovascular Society class III/IV angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mortality odds ratio for PVC-treated patients
Endpoint domain: Mortality/survival
Primary endpoint: time to commencement of antimicrobials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time to commencement of vasopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Depression scale scores (BDI and HAMD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NAA/Cr value in the prefrontal cortex and hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cho/Cr value in the prefrontal cortex and hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful breastfeeding initiation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to initiate first feed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median duration of weaning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emergency operations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: elective AAA operations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total continence or improvement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of emesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to first oral fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Homologous blood requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time taken for completion of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of immediate post-operative discomfort
Endpoint domain: Adverse events/effects